Free Trial
OTCMKTS:ENZN

Enzon Pharmaceuticals (ENZN) Stock Price, News & Analysis

Enzon Pharmaceuticals logo
$0.11 0.00 (-3.84%)
As of 03:57 PM Eastern

About Enzon Pharmaceuticals Stock (OTCMKTS:ENZN)

Key Stats

Today's Range
$0.11
$0.12
50-Day Range
$0.06
$0.13
52-Week Range
$0.06
$0.24
Volume
87,581 shs
Average Volume
66,512 shs
Market Capitalization
$8.36 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ENZN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ENZN Stock News Headlines

Enzon Pharmaceuticals, Inc. (ENZN) - Yahoo Finance
The $100 Trillion AI Story No One Is Telling You
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
Enzon and Viskase Enter into Merger Agreement
ENZN Enzon Pharmaceuticals, Inc.
See More Headlines

ENZN Stock Analysis - Frequently Asked Questions

Enzon Pharmaceuticals' stock was trading at $0.1561 at the start of the year. Since then, ENZN shares have decreased by 27.8% and is now trading at $0.1127.
View the best growth stocks for 2025 here
.

Enzon Pharmaceuticals Inc. (OTCMKTS:ENZN) issued its earnings results on Friday, May, 9th. The biotechnology company reported ($0.01) EPS for the quarter.

Shares of ENZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enzon Pharmaceuticals investors own include Biocept (BIOC), Aeterna Zentaris (AEZS), Energy Transfer (ET), DURECT (DRRX), Nymox Pharmaceutical (NYMX), OpGen (OPGN) and BioCryst Pharmaceuticals (BCRX).

Company Calendar

Last Earnings
5/09/2025
Today
7/02/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
OTCMKTS:ENZN
Previous Symbol
NASDAQ:ENZN
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$780 thousand
Pretax Margin
1,150.00%

Debt

Sales & Book Value

Annual Sales
$30 thousand
Cash Flow
$0.01 per share
Price / Cash Flow
12.11
Book Value
$0.04 per share
Price / Book
2.78

Miscellaneous

Free Float
73,918,000
Market Cap
$8.24 million
Optionable
Not Optionable
Beta
0.36

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (OTCMKTS:ENZN) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners